Received by email:

File: PP revised Final.docx

   Marapharm Ventures Inc.   
          CSE:MDM  FSE:2M0(zero)
      Unit #12  - 7621 Vantage Way, Delta  British Columbia  V4G 1A6    Telephone: 604-952-6676      Facsimile: 604-95
--->2-0988
     NEWS   RELEASE    LK31082015-2 Company Announces Oversubscribed Private Placement
August 31, 2015 - Vancouver, BC. - Les Kjosness, President & CEO of Marapharm Ventures Inc. (the 'Company'), (CSE: MDM
--->, FSE: 2M0,) is pleased to announce that its previously announced August 18, 2015 non-brokered private placement is ov
--->ersubscribed. Marapharm will issue a total of 1,100,000 units at a price of $0.37 per unit to raise gross proceeds of 
--->Cdn. $407,000. Each unit will consist of one common share and one share purchase warrant. Each full warrant entitles t
--->he holder to purchase one additional common share at an exercise price of $0.37 per share for a period of six months. 
--->No additional subscriptions will be accepted. 
Proceeds from the private placement will be utilized for corporate activities. A 10 percent Finder's fee may be payabl
--->e in securities of the Company. The private placement and finder's fee are subject to regulatory approval.
About Marapharm Ventures Inc. 
Marapharm was formed to create a global entity by pursuing commercial ventures in the medical marijuana business. The 
--->Company's original project is the construction of brand new facilities on 11 acres in British Columbia's Okanagan Vall
--->ey with expansion plans in place to meet strategic advantages for growth and market penetration. Marapharm is currentl
--->y in the process of its application for an MMPR license. In May 2015, we announced the purchase of 5.9 acres in the Ap
--->ex Industrial Park, located in North Las Vegas, Nevada. The Company has a provisional grow licence in place and will b
--->uild up to a 70,000 square foot medical marijuana facility. Completed building plans were revised and re-submitted for
---> permitting. In addition to the Las Vegas acquisition, Marapharm has entered into an LOI with the same business corpor
--->ation for a 90-day exclusive negotiation rights and the right of first refusal for two additional Nevada Medical Marij
--->uana licences, one grow operation and a medical dispensary licence in Washington State and one medical dispensary lice
--->nce in California. 

On behalf of the Board 
"Les Kjosness" 
President & Director 

For further information please visit the Company`s website at www.marapharm.com 
Les Kjosness: 604-952-6676: les@marapharm.com 

Bayside Management Ltd. 
Terry Yuck: terry@marapharm.com
Dwayne Sorobey: dwayne@marapharm.com
Tel: 1-403-861-5775 1-403-403-973-6251 

 The CSE has neither approved nor disapproved the accuracy of this news release.

This news release contains forward-looking information, which involves known and unknown risks, uncertainties and othe
--->r factors that may cause actual events to differ materially from current expectations. Important factors - including t
--->he availability of funds, the results of financing efforts, the results of exploration activities - that could cause a
--->ctual results to differ materially from the Company's expectations are disclosed in the Companies' documents filed fro
--->m time to time on SEDAR (see www.sedar.com). Readers are cautioned not to place undue reliance on these forward - look
--->ing statements, which speak only as of the date of this news release. The Company disclaims any intention or obligatio
--->n, except to the extent required by law, to update or revise any forward - looking statements, whether as a result of 
--->new information, future events or otherwise.